Publications
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Pathological cut-offs of global and regional brain volume loss in multiple sclerosis2019 | First Faculty of Medicine
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients2017 | First Faculty of Medicine
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome2015 | First Faculty of Medicine
- Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment2014 | First Faculty of Medicine
- Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study2013 | First Faculty of Medicine
- Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event2013 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
Loading network view...